Cue Biopharma (NASDAQ:CUE) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Cue Biopharma (CUE) operate in?

Cue Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Cue Biopharma Stock (NASDAQ: CUE) stock price, news, charts, stock research, profile.

Open	$1.08
Close	$0.98
Volume / Avg.	278.27K / 376.27K
Day Range	0.97 - 1.09
52 Wk Range	0.94 - 4.89
Market Cap	$52.05M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	32
Short Interest	9.3%
Days to Cover	16.79

Recent News

Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24 insurance revenue guidance.

Avi Kapoor

Cue Biopharma And 2 Other Stocks Under $3 Insiders Are Buying

The Dow Jones closed higher by close to 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Why Soluna Holdings Shares Are Trading Sharply Lower; Here Are 38 Stocks Moving Premarket

Gainers Applied Genetic Technologies Corporation (NASDAQ: AGTC) rose 70.8% to $0.41 in pre-market trading. Syncona disclosed that it will acquire Applied Genetic Technologies Corporation.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Cue Biopharma Inc

Sector

Health Care

Industry

Biotechnology

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and propri...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cue Biopharma (CUE) stock?

You can purchase shares of Cue Biopharma (NASDAQ:CUE) through any online brokerage.

View our list of the best stock brokerages

Who are Cue Biopharma (CUE) competitors?

Other companies in Cue Biopharma’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), CARISMA Therapeutics (NASDAQ:CARM), Barinthus Biotherapeutics (NASDAQ:BRNS), CollPlant Biotechnologies (NASDAQ:CLGN) and BioLine Rx (NASDAQ:BLRX).

What is the target price for Cue Biopharma (CUE) stock?

There is no analysis for Cue Biopharma.

What is the forecast for Cue Biopharma (CUE) stock?

Cue Biopharma has a consensus price target of $11.86.

Current stock price for Cue Biopharma (CUE)?

The stock price for Cue Biopharma (NASDAQ: CUE) is $1.07 last updated July 3, 2024 at 4:14 PM EDT.

Does Cue Biopharma (CUE) pay a dividend?

There are no upcoming dividends for Cue Biopharma.

When is Cue Biopharma (NASDAQ:CUE) reporting earnings?

Cue Biopharma’s Q2 earnings are confirmed for Wednesday, August 7, 2024.

Is Cue Biopharma (CUE) going to split?

There is no upcoming split for Cue Biopharma.

What sector and industry does Cue Biopharma (CUE) operate in?

Cue Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cue Biopharma

Cue Biopharma (CUE) Forecast